This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Hypertension (target blood pressure in Type I diabetics)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • NICE guidance states with respect to type 1 diabetes (1):
    • Blood pressure management
      • intervention levels for recommending blood pressure management should be 135/85 mmHg unless the adult with type 1 diabetes has albuminuria or 2 or more features of metabolic syndrome, in which case it should be 130/80 mmHg
      • start a trial of a renin-angiotensin system blocking drug as first-line therapy for hypertension in adults with type 1 diabetes

    • Do not allow concerns over potential side effects to inhibit advising and offering the necessary use of any class of drugs, unless the side effects become symptomatic or otherwise clinically significant. In particular:
      • do not avoid selective beta-adrenergic blockers where indicated in adults on insulin
      • low-dose thiazides may be combined with beta-blockers
      • when calcium channel antagonists are prescribed, use only long-acting preparations
      • use direct questioning to detect the potential side effects of erectile dysfunction, lethargy and orthostatic hypotension with different drug classes

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.